IGFs, Basic FGF, and Glucose Modulate Proliferation and Apoptosis Induced by IFNγ but not by IL-1β in Rat INS-1E β-cells

Abstract

We investigated the effects of glucose and β-cell growth factors (IGF-I, IGF-II, bFGF) on growth and apoptosis in the presence and absence of apoptosis inducing cytokines (IFNγ, Il-1β, TNFα). Rat INS-1E β-cell viability was measured by WST-1 viability assay and cell counting, apoptosis by FACS analysis of annexin-V-FITC and fluorescein-dUTP (TUNEL-staining)-positive cells. Glucose alone maintained INS-1E β-cell viability at high physiological concentrations (6.2 - 12.5 mmol/l), addition of IGF-II alone or in combination with bFGF further increased these glucose effects. The cytokines IFNg and IL-1β, but not TNFα strongly induced INS-1E β-cell apoptosis. Interestingly, glucose alone induced apoptosis at extremely low or very high concentrations. In combination with IFNg, low glucose (1.6 mmol/l) increased apoptosis by 25.6 % (1SD 5.0 %) and high glucose (50 mmol/l) by 22.8 % (1SD 2.8 %) compared to 12.5 mmol/l glucose. In contrast, glucose failed to modulate IL-1β-induced apoptosis. Most importantly, IGF-II and bFGF inhibited apoptosis induced by IFNg, but not by IL-1β. Therefore, IGF signaling, supported by bFGF and optimal glucose levels, maintains β-cell viability in vitro. Cytokines IFNg and IL-1β differentially interfere with intracellular signaling cascades stimulated by IGFs and bFGF or glucose, respectively.

Key words

Glucose - Growth factors - Cytokines - β-cells - Apoptosis

References

• 1 Laffranchi R, Spinas G A. Interferon-gamma inhibits insulin release and induces cell death in the pancreatic beta-cell line INS-1 independently of nitric oxide production.  Exp Cell Res. 1997;  237 217-222
• 2 Loweth A C, Williams G T, James R F, Scarpello J H, Morgan N G. Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation.  Diabetes. 1998;  47 727-732
• 3 Yoon J W, Jun H S. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.  Ann N Y Acad Sci. 2001;  928 200-211
• 4 Ou D, Metzger D L, Wang X, Huang J, Pozzilli P, Tingle A J. TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction.  Diabetologia. 2002;  45 1678-1688
• 5 Yamagata K, Nakajima H, Tomita K, Itoh N, Miyagawa J, Hamaguchi T, Namba M, Tamura S, Kawata S, Kono N, Kuwajima M, Noguchi T, Hanafusa T, Matsuzawa Y. Dominant TCR alpha-chain clonotypes and interferon-gamma are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus.  Diabetes Res Clin Pract. 1996;  34 37-46
• 6 Rabinovitch A, Suarez-Pinzon W, Strynadka K, Ju Q, Edelstein D, Brownlee M, Korbutt G S, Rajotte R V. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.  Diabetes. 1999;  48 1223-1229
• 7 Giannoukakis N, Mi Z, Rudert W A, Gambotto A, Trucco M, Robbins P. Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I.  Gene Ther. 2000;  7 2015-2022
• 8 Rhodes C J. IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication.  J Mol Endocrinol. 2000;  24 303-311
• 9 Raile K, Hoflich A, Kessler U, Yang Y, Pfuender M, Blum W F, Kolb H, Schwarz H P, Kiess W. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.  J Cell Physiol. 1994;  159 531-541
• 10 Gallaher B W, Hille R, Raile K, Kiess W. Apoptosis: live or die - hard work either way!.  Horm Metab Res. 2001;  33 511-519
• 11 Herzlieb N, Gallaher B W, Berthold A, Hille R, Kiess W. Insulin-like growth factor-I inhibits the progression of human U-2 OS osteosarcoma cells towards programmed cell death through interaction with the IGF-I receptor.  Cell Mol Biol (Noisy-le-grand). 2000;  46 71-77
• 12 Hill D J, Strutt B, Arany E, Zaina S, Coukell S, Graham C F. Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets.  Endocrinology. 2000;  141 1151-1157
• 13 Petrik J, Pell J M, Arany E, McDonald T J, Dean W L, Reik W, Hill D J. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic isleT-cell hyperplasia.  Endocrinology. 1999;  140 2353-2363
• 14 LeBras S, Czernichow P, Scharfmann R. A search for tyrosine kinase receptors expressed in the rat embryonic pancreas.  Diabetologia. 1998;  41 1474-1481
• 15 Hart A W, Baeza N, Apelqvist A, Edlund H. Attenuation of FGF signalling in mouse beta-cells leads to diabetes.  Nature. 2000;  408 864-868
• 16 Huotari M A, Palgi J, Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen.  Endocrinology. 1998;  139 1494-1499
• 17 Cousin S P, Hugl S R, Myers M G, Jr. , White M F, Reifel-Miller A, Rhodes C J. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.  Biochem J. 2000;  344 649-658
• 18 Maedler K, Spinas G A, Lehmann R, Sergeev P, Weber M, Fontana A, Kaiser N, Donath M Y. Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets.  Diabetes. 2001;  50 1683-1690
• 19 Rubi B, Ishihara H, Hegardt F G, Wollheim C B, Maechler P. GAD65-mediated glutamate decarboxylation reduces glucose-stimulated insulin secretion in pancreatic beta cells.  J Biol Chem. 2001;  276 36 391-36 396
• 20 Sekine N, Ishikawa T, Okazaki T, Hayashi M, Wollheim C B, Fujita T. Synergistic activation of NF-kappab and inducible isoform of nitric oxide synthase induction by interferon-gamma and tumor necrosis factor-alpha in INS-1 cells.  J Cell Physiol. 2000;  184 46-57
• 21 Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matsuzawa Y. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus.  Diabetologia. 1999;  42 1332-1340
• 22 Hernandez-Sanchez C, Werner H, Roberts C T, Woo E J, Hum D W, Rosenthal S M, LeRoith D. Differential regulation of insulin-like growth factor-I (IGF-I) receptor gene expression by IGF-I and basic fibroblastic growth factor.  J Biol Chem. 1997;  272 4663-4670
• 23 Dickson L M, Lingohr M K, McCuaig J, Hugl S R, Snow L, Kahn B B, Myers M G, Rhodes C J. Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1).  J Biol Chem. 2001;  276 21 110-21 120
• 24 Plas D R, Talapatra S, Edinger A L, Rathmell J C, Thompson C B. Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology.  J Biol Chem. 2001;  276 12 041-12 048
• 25 Gottlob K, Majewski N, Kennedy S, Kandel E, Robey R B, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.  Genes Dev. 2001;  15 1406-1418
• 26 Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang Z Y, Yamauchi T, Kuboki K, Meier M, Rhodes C J, King G L. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways.  J Clin Invest. 1999;  103 185-195
• 27 Butler A E, Janson J, Bonner-Weir S, Ritzel R, Rizza R A, Butler P C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.  Diabetes. 2003;  52 102-110
• 28 Barker D J, Hales C N, Fall C H, Osmond C, Phipps K, Clark P M. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.  Diabetologia. 1993;  36 62-67